HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build Unknown region code '840'

HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions

ValueSet: Hepatitis C Test Codes

Official URL: http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-b2-de103 Version: 0.1.0
Draft as of 2024-08-12 Computable Name: HepatitisCTestCodes

Copyright/Legal: Copyright National Association of Community Health Centers, Inc. (NACHC)

Codes representing possible values for the Hepatitis C Test element

References

Logical Definition (CLD)

Generated Narrative: ValueSet nachc-b2-de103

This value set includes codes based on the following rules:

  • Include these codes as defined in http://fhir.org/guides/nachc/hiv-cds/CodeSystem/hiv-custom
    CodeDisplayDefinition
    NACHC.B2.DE103Antinuclear antibodies (ANA)Hepatitis C Test - Antinuclear antibodies (ANA)
    NACHC.B2.DE104Hepatitis C antibodyHepatitis C Test - Hepatitis C antibody
    NACHC.B2.DE105Hepatitis C antibody; confirmatory test (eg, immunoblot)Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot)
    NACHC.B2.DE106Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe techniqueHepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique
    NACHC.B2.DE107Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performedHepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed
    NACHC.B2.DE108Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performedHepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed
    NACHC.B2.DE109Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virusHepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus
  • Include these codes as defined in http://www.ama-assn.org/go/cpt
    CodeDisplay
    1014274 Hepatitis C antibody
  • Include these codes as defined in https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets
    CodeDisplay
    G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s)

 

Expansion

No Expansion for this valueset (Unknown Code System)

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code